Universal Cells
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3005 1st Ave Ste 201, Seattle, Washingto...Phone Number
(206) 596-1852Website
www.universalcells.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Universal Cells
Universal Cells is a Seattle-based company specializing in engineered, allogeneic stem cells that can be differentiated into various therapeutic cells. They utilize nuclease-free, recombinant Adeno-Associated Virus (rAAV) gene editing technology to create universal donor, pluripotent stem cells for off-the-shelf, stem cell-based products. Their programs encompass basic discovery to product development, focusing on gene editing methods and producing cells for clinical trials. The company aims to advance the future of cell therapy and is open to innovative talent in the field.Explore more
Universal Cells Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Universal Cells your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Universal Cells is spiking on competitors!
Earning: See what the market has to say on Universal Cells recently announced quarterly report
Check if Universal Cells has recently received funding, and reach out quickly before it becomes old news!
Click to see if Universal Cells had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Universal Cells, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Universal Cells launches new products
Funding: Get notified immidiatlly once Universal Cells has new funding data
Congratulate Masked Content for being promoted to Masked Content at Universal Cells
Recommended Actions
Reach out to Masked Content who joined Universal Cells as Masked Content
Find more new buyers
Compare Similar Companies to Universal Cells
Compare insights from companies similar to Universal Cells, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Universal Cells is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Universal Cells is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Universal Cells.
Universal Cells Tech Stack
A closer look at the technologies used by Universal Cells
Universal Cells News & Media
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors
Collaboration leverages Ginkgo's cell engineering and screening platform to enhance the potency and persistence of Universal Cells' iPSC-derived immune cell therapeutics BOSTON, Jan. 13, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell...Astellas telegraphs new cell therapy site in Japan, 24 layoffs - Fierce Biotech
Some six years after picking up Seattle’s Universal Cells for $102 million, Astellas Pharma is opening a second location for the subsidiary in its home country of Japan—and transferring a dozen rol | Astellas subsidiary Universal Cells is establishing a second location overseas at the Japanese pharma’s research campus in Tsukuba. As part of the move, 24 roles held by Universal Cell employees in Seattle are being eliminated. However, 12 of the former Seattle-based rolesAstellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies
- Agreement covers the co-development and co-commercialization of up to three T-cell therapies -EY announces winners for the Entrepreneur Of The Year® 2018 Pacific Northwest Region Awards
EY builds on three decades of honoring entrepreneurs who break the mold EY builds on three decades of honoring entrepreneurs who break the mold
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Universal Cells
Sign Up For FreeTo access detailed company insights
Universal Cells is a Seattle-based company specializing in engineered, allogeneic stem cells that can be differentiated into various therapeutic cells. They utilize nuclease-free, recombinant Adeno-Associated Virus (rAAV) gene editing technology to create universal donor, pluripotent stem cells for off-the-shelf, stem cell-based products. Their pro... Read More
